These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 2551604

  • 1. [Prognostically relevant factors in ductal pancreatic cancer].
    Böttger T, Zech J, Weber W, Sorger K, Junginger T.
    Chirurg; 1989 Aug; 60(8):521-8. PubMed ID: 2551604
    [Abstract] [Full Text] [Related]

  • 2. Relevant factors in the prognosis of ductal pancreatic carcinoma.
    Böttger T, Zech J, Weber W, Sorger K, Junginger T.
    Acta Chir Scand; 1990 Aug; 156(11-12):781-8. PubMed ID: 1706125
    [Abstract] [Full Text] [Related]

  • 3. [Operative therapy of cancer of the head of the pancreas--determination of surgical status].
    Beger HG, Bittner R.
    Z Gastroenterol; 1985 May; 23(5):240-6. PubMed ID: 2417421
    [Abstract] [Full Text] [Related]

  • 4. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K, Meyer F, Schmidt U, Lippert H.
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [Abstract] [Full Text] [Related]

  • 5. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
    Helm J, Centeno BA, Coppola D, Melis M, Lloyd M, Park JY, Chen DT, Malafa MP.
    Cancer; 2009 Sep 15; 115(18):4080-9. PubMed ID: 19626671
    [Abstract] [Full Text] [Related]

  • 6. Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas.
    Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N.
    Hepatogastroenterology; 2006 Sep 15; 53(69):447-51. PubMed ID: 16795990
    [Abstract] [Full Text] [Related]

  • 7. Tumor markers in patients with pancreatic carcinoma.
    Gattani AM, Mandeli J, Bruckner HW.
    Cancer; 1996 Jul 01; 78(1):57-62. PubMed ID: 8646727
    [Abstract] [Full Text] [Related]

  • 8. Nonendocrine cancer of the pancreas in patients under age forty years.
    Ivy EJ, Sarr MG, Reiman HM.
    Surgery; 1990 Sep 01; 108(3):481-7. PubMed ID: 2168585
    [Abstract] [Full Text] [Related]

  • 9. Distal pancreatectomy--does it have a role for pancreatic body and tail cancer.
    Kayahara M, Nagakawa T, Ueno K, Ohta T, Kitagawa H, Arakawa H, Yagi H, Tajima H, Miwa K.
    Hepatogastroenterology; 1998 Sep 01; 45(21):827-32. PubMed ID: 9684142
    [Abstract] [Full Text] [Related]

  • 10. Tumor markers in pancreatic cancer. Sensitivity and specificity of CA 19-9.
    Safi F, Roscher R, Beger HG.
    Hepatogastroenterology; 1989 Dec 01; 36(6):419-23. PubMed ID: 2613165
    [Abstract] [Full Text] [Related]

  • 11. [Prognostic factors in pancreatic cancer].
    Höfler H.
    Chirurg; 1994 Apr 01; 65(4):253-7. PubMed ID: 8020344
    [Abstract] [Full Text] [Related]

  • 12. [Factors influencing long-term prognosis after pancreatoduodenectomy in cancer of the pancreas head].
    Liang XM.
    Zhonghua Wai Ke Za Zhi; 1989 Apr 01; 27(4):211-4, 253. PubMed ID: 2553357
    [Abstract] [Full Text] [Related]

  • 13. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
    Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N.
    Ann Surg Oncol; 2007 Nov 01; 14(11):3174-80. PubMed ID: 17694416
    [Abstract] [Full Text] [Related]

  • 14. Extended radical pancreatectomy for carcinoma of the head of the pancreas.
    Nagakawa T, Konishi I, Ueno K, Ohta T, Kayahara M, Miyazaki I.
    Hepatogastroenterology; 1998 Nov 01; 45(21):849-54. PubMed ID: 9684146
    [Abstract] [Full Text] [Related]

  • 15. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
    Skalicky DA, Kench JG, Segara D, Coleman MJ, Sutherland RL, Henshall SM, Musgrove EA, Biankin AV.
    Cancer Epidemiol Biomarkers Prev; 2006 Oct 01; 15(10):1941-7. PubMed ID: 17035403
    [Abstract] [Full Text] [Related]

  • 16. [Clinico-pathological study on the appropriate range of pancreatic resection to obtain operative curability of pancreatic head cancer].
    Ishikawa O, Oohigashi H, Imaoka S, Sasaki Y, Kameyama M, Kabuto T, Fukuda I, Furukawa H, Koyama H, Taniguchi K.
    Nihon Geka Gakkai Zasshi; 1984 Apr 01; 85(4):363-9. PubMed ID: 6087110
    [Abstract] [Full Text] [Related]

  • 17. Pancreatic liver metastases after curative resection combined with intraoperative radiation for pancreatic cancer.
    Takamori H, Hiraoka T, Kanemitsu K, Tsuji T.
    Hepatogastroenterology; 2004 Apr 01; 51(59):1500-3. PubMed ID: 15362786
    [Abstract] [Full Text] [Related]

  • 18. Progress in the diagnosis and treatment of pancreatic cancer--the Kyoto University experience.
    Manabe T, Tobe T.
    Hepatogastroenterology; 1989 Dec 01; 36(6):431-6. PubMed ID: 2693297
    [Abstract] [Full Text] [Related]

  • 19. Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival.
    Kato K, Yamada S, Sugimoto H, Kanazumi N, Nomoto S, Takeda S, Kodera Y, Morita S, Nakao A.
    Pancreas; 2009 Aug 01; 38(6):605-12. PubMed ID: 19629002
    [Abstract] [Full Text] [Related]

  • 20. [Tumor markers in the upper intestinal tract--stomach and pancreas].
    Pointner R, Conrad F, Schwab G.
    Wien Klin Wochenschr; 1989 Jul 14; 101(14):482-4. PubMed ID: 2773485
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.